Table 4.
Validation of predictive factors for TIA (n = 377; number of events = 92)
| Agec | HT | DM | Age + HT | Age + DM | HT + DM | Age + HT + DM | ||
|---|---|---|---|---|---|---|---|---|
| Single risk | TIA ( +) | 73 | 60 | 27 | 53 | 25 | 21 | 21 |
| TIA (-) | 79 | 57 | 11 | 28 | 5 | 5 | 2 | |
| PPVd | 48.0% | 51.3% | 71.1% | 65.4% | 83.3% | 80.8% | 91.3% | |
| Single risk + ALDOA-Aba | TIA ( +) | 53 | 47 | 21 | 41 | 20 | 17 | 17 |
| TIA (-) | 31 | 27 | 2 | 12 | 1 | 0 | 0 | |
| PPV | 63.1% | 63.5% | 91.3% | 77.4% | 95.2% | 100.0% | 100.0% | |
| Single risk + FH-Abb | TIA ( +) | 39 | 33 | 16 | 29 | 14 | 14 | 13 |
| TIA (-) | 24 | 25 | 1 | 12 | 0 | 1 | 0 | |
| PPV | 61.9% | 56.9% | 94.1% | 70.7% | 100.0% | 93.3% | 100.0% | |
| Single risk + ALDOA-Ab + FH-Ab | TIA ( +) | 32 | 29 | 15 | 25 | 14 | 13 | 13 |
| TIA (-) | 11 | 14 | 0 | 7 | 0 | 0 | 0 | |
| PPV | 74.4% | 67.4% | 100.0% | 78.1% | 100.0% | 100.0% | 100.0% |
aADOLA-Ab, elevated ADOLA-Ab levels, > 14,869
bFH-Ab, elevated FH-Ab levels, > 2,849
cAge, ≥ 60
dPPV, positive predictive value